Tega Industries Limited (TEGA)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- H1 FY27 consolidated revenue INR59,775m; EBITDA margin 14.4% before one-time costs
- Tega legacy consumables revenue +30% y-y; EBITDA margin expanded 190 bps to 22.4%
- Molycop Q2 revenue INR37,716m; EBITDA INR5,144m at 14% margin
- Order book INR13,976m, 83% executable in 12 months
- Cross-selling trial of 500 tons grinding media secured; potential 20-30k tons
- Finance cost elevated due to acquisition; deleveraging and asset sales underway
- Molycop volume growth 2.2% over 4 months; margins stable, expected to improve 100 bps
- Equipment business subdued H1; strong recovery expected in H2
- Synergy cost savings target US$20m over 2-2.5 years; margin expansion initiatives ongoing
- Tax rate elevated this quarter; expected to normalize going forward
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 TEGA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add TEGA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Tega Industries Limited
Important.
The summary above is generated automatically from Tega Industries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.